Allianz Asset Management’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-22,300
| Closed | -$554K | – | 1735 |
|
2025
Q1 | $554K | Hold |
22,300
| – | – | ﹤0.01% | 1393 |
|
2024
Q4 | $420K | Buy |
22,300
+5,600
| +34% | +$106K | ﹤0.01% | 1455 |
|
2024
Q3 | $251K | Buy |
+16,700
| New | +$251K | ﹤0.01% | 1570 |
|
2017
Q2 | – | Sell |
-21,100
| Closed | -$962K | – | 2121 |
|
2017
Q1 | $962K | Buy |
+21,100
| New | +$962K | ﹤0.01% | 1733 |
|
2016
Q4 | – | Sell |
-53,137
| Closed | -$1.82M | – | 2089 |
|
2016
Q3 | $1.82M | Buy |
+53,137
| New | +$1.82M | ﹤0.01% | 1521 |
|
2015
Q2 | – | Sell |
-214,773
| Closed | -$19.1M | – | 1986 |
|
2015
Q1 | $19.1M | Sell |
214,773
-54,479
| -20% | -$4.84M | 0.02% | 641 |
|
2014
Q4 | $23.9M | Buy |
269,252
+10,601
| +4% | +$940K | 0.03% | 560 |
|
2014
Q3 | $24.9M | Buy |
258,651
+88,656
| +52% | +$8.54M | 0.03% | 544 |
|
2014
Q2 | $15.6M | Buy |
169,995
+55,110
| +48% | +$5.06M | 0.02% | 627 |
|
2014
Q1 | $8.04M | Buy |
114,885
+17,572
| +18% | +$1.23M | 0.01% | 803 |
|
2013
Q4 | $5.6M | Sell |
97,313
-12,197
| -11% | -$701K | 0.01% | 902 |
|
2013
Q3 | $5.27M | Sell |
109,510
-135,890
| -55% | -$6.53M | 0.01% | 890 |
|
2013
Q2 | $7.12M | Buy |
+245,400
| New | +$7.12M | 0.01% | 740 |
|